Cardiome Pharma Corp. announced that Robert James Meyer, M.D. has joined its board of directors. Dr. Meyer is currently a Director at the Virginia Center for Translational and Regulatory Sciences at the University of Virginia School of Medicine, but has held senior roles at Merck Research Laboratories from 2007 to 2013, most recently as Vice President, Global Regulatory Strategy, Policy and Safety, as well as at the U.S. Food and Drug Administration (FDA) from 1999 to 2007 where Dr. Meyer served as Director of the Division of Pulmonary and Allergy Drug Products and then Director of the Office of Drug Evaluation II in the Center for Drug Evaluation and Research.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
1st Jan change | Capi. | |
---|---|---|
+3.70% | 27.65M | |
+19.22% | 80.29B | |
+15.04% | 9.2B | |
-20.02% | 4.67B | |
+49.11% | 4.49B | |
+10.17% | 4.27B | |
+10.55% | 2.25B | |
-25.97% | 2.13B | |
+16.34% | 2.1B | |
-40.85% | 1.78B |
- Stock Market
- Equities
- CORV Stock
- News Correvio Pharma Corp.
- Cardiome Pharma Corp. Announces Addition of Robert James Meyer to Board of Directors